Ca 125(Clia)

The CA 125 Test is conducted to measure the amount of Cancer Antigen 125 (or CA 125) present in the blood. The Cancer Antigen 125 is a kind of protein or an antigen that is considered to be a tumur marker in women. This test is also used to monitor treatment for ovarian cancer or to detect recurrence; sometimes to evaluate a pelvic mass and it can also be ordered to help detect early ovarian cancer in those identified as being at high risk. By testing the levels of CA 125 and interpreting the CA 125 Test results, healthcare practitioners can often determine if the patient is at high risk of developing cancer or if they already have a type of cancer. Despite the many uses of the CA 125 Test, many healthcare authorities do not consider the test to be a good measure of screening for cancer in women who are at average risk of getting cancer. Instead, the CA 125 Test is considered to be a good test for cancer diagnosis in women who are at a high risk of developing any kind of cancer like ovarian cancer, pancreatic cancer, breast cancer, etc. In India, breast cancer and ovarian cancer continue to be major causes of female deaths to date. Many Indian women don’t get diagnosed at an early stage, which then results in a fatal outcome. Breast cancer and ovarian cancer awareness drives have been doing their best all over the country to encourage people not to ignore their condition and get tested if they suspect any abnormalities. So, for women who are already at a high risk of developing cancer (maybe due to a family history of cancer cases), getting the CA 125 Test is a wise preventive measure.